These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 23697553)
1. Mesenchymal stem cell therapy in horses: useful beyond orthopedic injuries? De Schauwer C; Van de Walle GR; Van Soom A; Meyer E Vet Q; 2013 Dec; 33(4):234-41. PubMed ID: 23697553 [TBL] [Abstract][Full Text] [Related]
2. Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse. Barrachina L; Romero A; Zaragoza P; Rodellar C; Vázquez FJ Vet J; 2018 Aug; 238():49-57. PubMed ID: 30103915 [TBL] [Abstract][Full Text] [Related]
3. Use of Stem Cells for the Treatment of Musculoskeletal Injuries in Horses. Watts AE Vet Clin North Am Equine Pract; 2023 Dec; 39(3):475-487. PubMed ID: 37625917 [TBL] [Abstract][Full Text] [Related]
4. The regenerative medicine laboratory: facilitating stem cell therapy for equine disease. Borjesson DL; Peroni JF Clin Lab Med; 2011 Mar; 31(1):109-23. PubMed ID: 21295725 [TBL] [Abstract][Full Text] [Related]
5. The Role of Mesenchymal Stem Cells (MSCs) in Veterinary Medicine and Their Use in Musculoskeletal Disorders. Prządka P; Buczak K; Frejlich E; Gąsior L; Suliga K; Kiełbowicz Z Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439807 [TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cell therapy in equine musculoskeletal disease: scientific fact or clinical fiction? Taylor SE; Smith RK; Clegg PD Equine Vet J; 2007 Mar; 39(2):172-80. PubMed ID: 17378447 [TBL] [Abstract][Full Text] [Related]
7. The current 'state of play' of regenerative medicine in horses: what the horse can tell the human. Smith RK; Garvican ER; Fortier LA Regen Med; 2014; 9(5):673-85. PubMed ID: 25372081 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells for treatment of musculoskeletal disease in horses: Relative merits of allogeneic versus autologous stem cells. Colbath AC; Dow SW; McIlwraith CW; Goodrich LR Equine Vet J; 2020 Sep; 52(5):654-663. PubMed ID: 31971273 [TBL] [Abstract][Full Text] [Related]
9. Subconjunctival bone marrow-derived mesenchymal stem cell therapy as a novel treatment alternative for equine immune-mediated keratitis: A case series. Davis AB; Schnabel LV; Gilger BC Vet Ophthalmol; 2019 Sep; 22(5):674-682. PubMed ID: 30715781 [TBL] [Abstract][Full Text] [Related]
10. HORSE SPECIES SYMPOSIUM: Use of mesenchymal stem cells in fracture repair in horses. Govoni KE J Anim Sci; 2015 Mar; 93(3):871-8. PubMed ID: 26020865 [TBL] [Abstract][Full Text] [Related]
11. Commercial cell-based therapies for musculoskeletal injuries in horses. Gutierrez-Nibeyro SD Vet Clin North Am Equine Pract; 2011 Aug; 27(2):363-71. PubMed ID: 21872764 [TBL] [Abstract][Full Text] [Related]
12. Targeted transcriptomic analysis of synovial tissues from horses with septic arthritis treated with immune-activated mesenchymal stromal cells reveals induction of T-cell response pathways. Pezzanite LM; Chow L; Engiles JB; Kurihara J; Plaisance C; Goodrich LR; Dow S J Am Vet Med Assoc; 2024 Jun; 262(S1):S73-S82. PubMed ID: 38295517 [TBL] [Abstract][Full Text] [Related]
13. Autologous bone marrow mesenchymal stromal cells for regeneration of injured equine ligaments and tendons: a clinical report. Renzi S; Riccò S; Dotti S; Sesso L; Grolli S; Cornali M; Carlin S; Patruno M; Cinotti S; Ferrari M Res Vet Sci; 2013 Aug; 95(1):272-7. PubMed ID: 23419936 [TBL] [Abstract][Full Text] [Related]
14. Therapeutics prior to mesenchymal stromal cell therapy improves outcome in equine orthopedic injuries. Bernardino PN; Smith WA; Galuppo LD; Espinosa-Mur P; Cassano JM Am J Vet Res; 2022 Aug; 83(10):. PubMed ID: 35973004 [TBL] [Abstract][Full Text] [Related]
15. Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon. Guest DJ; Smith MR; Allen WR Equine Vet J; 2010 Oct; 42(7):636-42. PubMed ID: 20840579 [TBL] [Abstract][Full Text] [Related]
16. One health in regenerative medicine: report on the second Havemeyer symposium on regenerative medicine in horses. Fortier LA; Goodrich LR; Ribitsch I; Schnabel LV; Shepard DO; Van de Walle GR; Watts AE; Whealands Smith RK Regen Med; 2020 Jun; 15(6):1775-1787. PubMed ID: 32808582 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory effects of autologous, genetically modified autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses. Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL Vet Comp Orthop Traumatol; 2013; 26(6):453-60. PubMed ID: 24080668 [TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cell licensing: enhancing MSC function as a translational approach for the treatment of tendon injury. Koch DW; Schnabel LV Am J Vet Res; 2023 Sep; 84(10):1-8. PubMed ID: 37669745 [TBL] [Abstract][Full Text] [Related]
19. Treatment of Naturally Occurring Tendon Disease with Allogeneic Multipotent Mesenchymal Stromal Cells: A Randomized, Controlled, Triple-Blinded Pilot Study in Horses. Burk J; Wittenberg-Voges L; Schubert S; Horstmeier C; Brehm W; Geburek F Cells; 2023 Oct; 12(21):. PubMed ID: 37947591 [TBL] [Abstract][Full Text] [Related]
20. Isolation, growth and differentiation of equine mesenchymal stem cells: effect of donor, source, amount of tissue and supplementation with basic fibroblast growth factor. Colleoni S; Bottani E; Tessaro I; Mari G; Merlo B; Romagnoli N; Spadari A; Galli C; Lazzari G Vet Res Commun; 2009 Dec; 33(8):811-21. PubMed ID: 19472068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]